The molecular mechanisms underlying Golgi retention of glycosyltransferases

高尔基体保留糖基转移酶的分子机制

基本信息

  • 批准号:
    10680590
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

Glycosyltransferases in the Golgi apparatus are type-II membrane proteins which consist of an N-terminal cytoplasmic region, a trans membrane region, a stem region and a c-terminal catalytic region facing to lumen of Golgi. In order to elucidate the molecular mechanisms underlying Golgi retention of glycosyl-transferases, we carried out the following two experiments.(1) Molecular behavior of mutant Lewis enzymes in vivo : The expression of type-1 Lewis antigens on erythrocytes and in digestive organs is determined by a Lewis type α(1, 3/1, 4)fucosyltransferase (Lewis enzyme) encoded by the FUT3 gene (Lewis gene) . We have classified the Lewis alleles in the Japanese population into four types, the wild-type allele (Le) and three mutated alleles, le1, le2, and le3. We carried out an extensive study on the biological properties of the three mutant Lewis enzymes using native tissues. The missense mutation, Leu20 to Arg, in the transmembrane domain reduces retention of the le3 enzyme in th … More e Golgi membrane resulting in an apparent reduction of enzyme activity as revealed by the lack of Lewis antigen synthesis. So the le3 enzyme can not synthesize Lewis-active glycolipids, which result in the Lewis antigen-negative phenotype of erythrocytes.(2) Cloning and identification of genes encoding proteins interacting with glycosyltransferases : The two-hybrid system is an in vivo yeast-based system that identifies interaction between two proteins by reconstituting active transcription factor dimmers. cDNAs have been prepared from human non-cancerous right hemi-colon tissues obtained as a surgical sample and a cDNA library constructed in the GAL4 activation domain vector pPC86. We have reported that Lewis type α1, 3/1, 4 fucosyltransferase (FUT3) , H enzyme, Se enzyme, α2,3sialyltransferases (ST3Gal I and ST3Gal IV) and β1,4galactosyl-transferase I(β1,4Galt I) are all expressed in the normal right hemi-colon. Their genes have been cloned in frame with the GAL4 sequence encoding the DNA-binding domain into pDBLeu as the "bait". We carried out screening and obtained clones as the candidate molecules interacting with glycosyltransferases. Less
高尔基体中的糖基转移酶是由N端细胞质区域、跨膜区域、茎区域和面向高尔基体腔的c末端催化区域组成的II型膜蛋白。为了阐明高尔基体保留糖基转移酶的分子机制,我们进行了以下两个实验:(1)突变的刘易斯酶在体内的分子行为:1型刘易斯抗原在红细胞和消化器官中的表达是由FUT3基因(刘易斯基因)编码的刘易斯类型α(1,3/1,4)岩藻糖基转移酶(刘易斯酶)决定的。我们将日本人群中的Lewis等位基因分为四种类型,野生型等位基因(Le)和三种突变等位基因LE1、Le2和LE3。我们利用天然组织对三种突变的Lewis酶的生物学特性进行了广泛的研究。跨膜区的错义突变,Leu20到Arg,减少了LE3酶在TH…中的保留较多的E高尔基膜导致酶活性明显降低,这表现为缺乏Lewis抗原的合成。因此,LE3酶不能合成Lewis活性糖脂,从而导致红细胞Lewis抗原阴性表型。(2)糖基转移酶相互作用蛋白编码基因的克隆和鉴定:双杂交系统是一个基于酵母的体内系统,通过重组活性转录因子二聚体来鉴定两种蛋白之间的相互作用。从手术标本和构建在GAL4激活域载体pPC86中的人非癌右半结肠组织中提取了cDNA。我们已经报道,在正常右半结肠中,刘易斯α1,3/1,4岩藻糖基转移酶、H酶、Se酶、α2,3唾液酸基转移酶(ST3GalI和ST3GalIV)和β1,4半乳糖基转移酶I(β1,4GalI)均有表达。它们的基因与编码DNA结合区的GAL4序列一起被克隆到pDBLeu中作为诱饵。我们进行了筛选,获得了与糖基转移酶相互作用的候选分子克隆。较少

项目成果

期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kaneko,M.et al.: "α1,3-fucosyltransfer ase IX (Fuc-TIX) is very highly conserved between human and mouse;Molecular cloning,characterization and tissue distribution of human Fuc-TIX."FEBS Lett.. 453. 237-242 (1999)
Kaneko, M. 等人:“α1,3-岩藻糖基转移酶 IX (Fuc-TIX) 在人和小鼠之间高度保守;人 Fuc-TIX 的分子克隆、表征和组织分布。”FEBS Lett.. 453。 237-242 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Togayachi,A.et al.: "Upregulation of Lewis enzyme (Fuc-TIII) and plasma-type α1,3-fucosyl-transferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer."Int.J.Cancer. 83. 70-79 (1999)
Togayachi, A. 等人:“Lewis 酶 (Fuc-TIII) 和血浆型 α1,3-岩藻糖基转移酶 (Fuc-TVI) 表达的上调决定了非小细胞肺中唾液酸 Lewis x 抗原的表达增强癌症。”Int.J.Cancer.83. 70-79 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishihara,S.et al.: "α1,3-fucosyltransferase 9 (FUT9;Fuc-TIX) preferentially fucosylates the distal GlcNAc residue of polylactosamine chain while the other four α1,3FUT members preferentially fucosylate the inner GlcNAc residue."FEBS Lett.. 462. 289-294 (
Nishihara, S. 等人:“α1,3-岩藻糖基转移酶 9 (FUT9;Fuc-TIX) 优先岩藻糖基化聚乳糖胺链的远端 GlcNAc 残基,而其他四个 α1,3FUT 成员优先岩藻糖基化内部 GlcNAc 残基。”FEBS Lett。 462.289-294(
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kudo, T.: "Quantitative analysis of glycosyltransferase gene expression in human normal and cancerous colorectal tissue." Lab.Invest.79. 797-811 (1998)
Kudo, T.:“人类正常和癌性结直肠组织中糖基转移酶基因表达的定量分析。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Issiki, S. et al.: "Cloning, expression and characterization of a novel UDP-galactose : β-N-acetyl-glucosamine β1, 3-galactosyltransferase(β3Gal-T5)pancreatic epithelia and tumor cells derived therefrom"J. Biol. Chem.. 274. 12499-12507 (1999)
Issiki, S. 等人:“新型 UDP-半乳糖:β-N-乙酰基-葡糖胺 β1, 3-半乳糖基转移酶 (β3Gal-T5) 胰腺上皮细胞和源自其的肿瘤细胞的克隆、表达和表征”J. Biol。化学..274.12499-12507(1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIHARA Shoko其他文献

NISHIHARA Shoko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIHARA Shoko', 18)}}的其他基金

Screening of the glycans regulating stemness and differentiation of hematopoietic stem cells
调节造血干细胞干性和分化的聚糖的筛选
  • 批准号:
    24659468
  • 财政年份:
    2012
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of physiological function of su l fat i on by regulating the expression of PAPS transporter
调节PAPS转运蛋白表达分析硫脂肪的生理功能
  • 批准号:
    20370051
  • 财政年份:
    2008
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular system of Golgi retentior of glycosyltransferases
糖基转移酶高尔基体保留分子系统
  • 批准号:
    12680620
  • 财政年份:
    2000
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Deciphering the logic circuit for Golgi membrane traffic
破译高尔基膜交通的逻辑电路
  • 批准号:
    10329248
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
Deciphering the logic circuit for Golgi membrane traffic
破译高尔基膜交通的逻辑电路
  • 批准号:
    10557834
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
Investigation of MTCL proteins which regulate assembly structures of microtubules based on the Golgi membrane.
研究调节基于高尔基膜的微管组装结构的 MTCL 蛋白。
  • 批准号:
    22H02621
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of a new intracellular proteolysis mechanism GOMED using Golgi membrane
利用高尔基膜分析新的细胞内蛋白水解机制GOMED
  • 批准号:
    20K07353
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The control of p97-mediated Golgi membrane fusion and the ubiquitination
p97介导的高尔基体膜融合和泛素化的控制
  • 批准号:
    16K07353
  • 财政年份:
    2016
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of the Mechanism Regulating Golgi-Specific Brefeldin A Resistance Factor 1 (GBF1) Activity at the cis-Golgi Membrane
顺式高尔基膜上高尔基特异性布雷菲德菌素 A 抗性因子 1 (GBF1) 活性调节机制的表征
  • 批准号:
    331372
  • 财政年份:
    2014
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Studentship Programs
Cell cycle regulation of Golgi membrane dynamics
高尔基体膜动力学的细胞周期调节
  • 批准号:
    8026349
  • 财政年份:
    2011
  • 资助金额:
    $ 2.5万
  • 项目类别:
Cell cycle regulation of Golgi membrane dynamics
高尔基体膜动力学的细胞周期调节
  • 批准号:
    8598095
  • 财政年份:
    2011
  • 资助金额:
    $ 2.5万
  • 项目类别:
CELL CYCLE REGULATION OF GOLGI MEMBRANE DYNAMICS
高尔基膜动力学的细胞周期调节
  • 批准号:
    9106578
  • 财政年份:
    2011
  • 资助金额:
    $ 2.5万
  • 项目类别:
Cell cycle regulation of Golgi membrane dynamics
高尔基体膜动力学的细胞周期调节
  • 批准号:
    8209003
  • 财政年份:
    2011
  • 资助金额:
    $ 2.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了